[
  {
    "ts": "2025-12-09T12:30:00+00:00",
    "headline": "Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants",
    "summary": "HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced two new hires to its team for CNSide Diagnostics, LLC, its wholly-owned subsidiary. “We are strategically building the team to bolster our capabilities as we scale up our laboratory operations to address the largely unt",
    "url": "https://finance.yahoo.com/news/plus-therapeutics-announces-expansion-cnside-123000798.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "019bff20-89fa-3cff-adb7-ca045712b6db",
      "content": {
        "id": "019bff20-89fa-3cff-adb7-ca045712b6db",
        "contentType": "STORY",
        "title": "Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants",
        "description": "",
        "summary": "HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced two new hires to its team for CNSide Diagnostics, LLC, its wholly-owned subsidiary. “We are strategically building the team to bolster our capabilities as we scale up our laboratory operations to address the largely unt",
        "pubDate": "2025-12-09T12:30:00Z",
        "displayTime": "2025-12-09T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/074aebb13f06b6153b38a42de867fde2",
          "originalWidth": 1566,
          "originalHeight": 896,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MJ9f70ufm3I4X.VW_ofzwg--~B/aD04OTY7dz0xNTY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/074aebb13f06b6153b38a42de867fde2.cf.webp",
              "width": 1566,
              "height": 896,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sSgMXJ76eTj.gy2iYU5_7w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/074aebb13f06b6153b38a42de867fde2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/plus-therapeutics-announces-expansion-cnside-123000798.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/plus-therapeutics-announces-expansion-cnside-123000798.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PSTV"
            },
            {
              "symbol": "HUM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]